跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 偉民
助理教授
,
口腔衛生學系
https://orcid.org/0000-0002-6899-4043
電子郵件
weiminchang
tmu.edu
tw
h-index
697
引文
14
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2024
每年研究成果
概覽
指紋
網路
專案
(3)
研究成果
(28)
資料集
(3)
類似的個人檔案
(6)
指紋
查看啟用 Wei-Min Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Absence
21%
Activin A
21%
Biological Marker
19%
Cancer Cell
33%
Cancer Growth
23%
Carcinogen
21%
Catenin
28%
Cell Growth
21%
Cell Invasion
16%
Ceruloplasmin
21%
Circulating microRNA
21%
Colorectal Cancer
21%
Cytotoxicity
21%
down Regulation
44%
Fas Ligand
21%
Fructose Bisphosphate Aldolase
18%
Gelatinase B
21%
Genetic Variability
21%
Glucose Transporter 4
21%
Head and Neck Cancer
66%
Head and Neck Squamous Cell Carcinoma
100%
Hepatocellular Carcinoma
21%
Hypoxia Inducible Factor 1
21%
In Vitro
17%
Irinotecan
21%
Iron Balance
21%
Long Untranslated RNA
21%
Lung Adenocarcinoma
45%
Lung Cancer
30%
Lung Metastasis
21%
Lymph Node Metastasis
24%
Malignant Neoplasm
50%
Metastatic Carcinoma
80%
microRNA
28%
Mouth Squamous Cell Carcinoma
73%
Neoplasm
16%
Nodular Melanoma
21%
Non Small Cell Lung Cancer
24%
Oral Cancer
64%
Parathyroid Hormone
21%
Prasterone
21%
Programmed Cell Death
29%
Proteomics
42%
Receptor
21%
Signal Transduction
33%
Squamous Cell Carcinoma Cell
29%
Sulfotransferase
21%
Timbetasin
21%
Tumor-Associated Glycoprotein 72
21%
Upregulation
45%
Biochemistry, Genetics and Molecular Biology
Activin
21%
Aldo-Keto Reductase
21%
Aldolase A
18%
Cancer Cell
52%
Catenin
39%
Cell Death
21%
Cell Growth
26%
Cell Viability
17%
Ceruloplasmin
21%
Cisplatin
21%
Colony Forming Unit S
14%
Computer Model
19%
Dehydroepiandrosterone
21%
down Regulation
65%
Eicosanoid Receptor
21%
Epidermal Growth Factor Receptor
35%
Ferroxidase
21%
Gelatinase B
21%
Genetic Divergence
21%
Genotyping
21%
Glucose Transporter
21%
GLUT4
21%
Hypoxia Inducible Factor 1
21%
IDH1
21%
Iron Balance
21%
JAG1
21%
Liquid Chromatography
13%
Long Non-Coding RNA
21%
Mesenchymal-Epithelial Transition
17%
Messenger RNA
16%
Microarrays
15%
MicroRNA
64%
MMP9
21%
Overall Survival
32%
Parathyroid Hormone
21%
PD-L1
21%
Piper Betle
32%
Proteoglycan
21%
Proteomics
42%
RNA
13%
RUNX2
42%
Signal Transduction
39%
Single-Nucleotide Polymorphism
16%
STAT1
26%
Sulfotransferase
21%
Tandem Mass Spectrometry
13%
Thymosin Beta-4
21%
Transfection
16%
TXNIP
21%
Upregulation
47%
Pharmacology, Toxicology and Pharmaceutical Science
Activin A
21%
Aldo Keto Reductase
21%
Antagomir
10%
Antimetastatic Agent
21%
Biological Marker
8%
C57BL 6 Mouse
8%
C57BL Mouse
21%
Cancer Growth
21%
Catenin
13%
Ceruloplasmin
21%
Chondroitin Sulfate
7%
Cirsium
21%
Cisplatin
21%
Colorectal Cancer
21%
Fas Ligand
21%
Fructose Bisphosphate Aldolase
18%
Gelatinase B
42%
Glycoprotein
21%
Head and Neck Cancer
46%
Head and Neck Squamous Cell Carcinoma
84%
Hepatoprotection
8%
Hypoxia Inducible Factor 1
21%
Interferon
6%
Irinotecan
21%
Liver Cell Carcinoma
21%
Luciferase
10%
Lung Cancer
26%
Lung Metastasis
21%
Lymph Node Metastasis
22%
Malignant Neoplasm
55%
Matrix Metalloproteinase
6%
Metastasis
26%
microRNA
42%
Mouse Model
7%
Mouth Cancer
66%
Mouth Squamous Cell Carcinoma
71%
Neoplasm
33%
Non Small Cell Lung Cancer
24%
Norcantharidin
21%
Phenol
8%
Piper Betle
6%
Prasterone
21%
Receptor
21%
Recurrent Disease
6%
Silymarin
21%
Sulfotransferase
21%
Suppressor of Cytokine Signaling
10%
Suppressor of Cytokine Signaling 2
10%
Tacrine
21%
Timbetasin
21%
